NARA Discovery
Article Details
← Back to Search Results
Journal Article

Characterizing pancreatic cancer-associated fibroblast heterogeneity in vascular microphysiological systems

Charles W. Blackledge; Sarah Gullion; Ian McCabe; Ngan N. K. Van; Arthi Hariharan; Changfei Luan; Xianlu Laura Peng; William J. Polacheck; Jen Jen Yeh; Sarah E. Shelton
Angiogenesis · Vol. 29, Issue 3 · 2026

Abstract

Pancreatic Ductal Adenocarcinoma (PDAC), one of the deadliest cancer types, is dominated by a tumor microenvironment (TME) that is desmoplastic, immunosuppressive, and generally unresponsive to conventional cancer treatments. Cancer-Associated Fibroblasts (CAFs) are thought to drive many of the features of PDAC that contribute to treatment resistance, yet CAFs exhibit wide phenotypic heterogeneity with unclear biological and clinical implications. Recent work has identified CAF subtypes – tumor-restraining CAFs (RestCAFs) or tumor-promoting CAFs (ProCAFs) – that correlate with overall survival. Therefore, this study aims to identify CAF subtype-dependent functional effects in the TME using 3D microphysiological systems, focusing primarily on their interactions with vasculature. Microfluidic devices including a RestCAF line demonstrated increased levels of vasculogenesis and extracellular matrix remodeling, while devices containing a ProCAF line exhibited increased angiogenic sprouting and differential immune cell recruitment, such as monocyte migration into the TME. This work provides novel insights into the heterogeneous functions of CAFs in the TME and lays important groundwork for the development of CAF-targeted therapies in PDAC.

Bibliographic Information

JournalAngiogenesis
PublisherSpringer
Publication Date2026-06-09
Publication Year2026
Volume29
Issue3
Document TypeJournal Article
eISSN1573-7209
DOI10.1007/s10456-026-10061-9

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10456
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.